about
Characterizing the anti-HIV activity of papuamide AA simplified system for generating recombinant adenovirusesCellular Senescence:Ex Vivop53-Dependent Asymmetric Cell KineticsA Broad Overview and Review of CRISPR-Cas Technology and Stem CellsGenetic manipulation of schistosomes--progress with integration competent vectorsTanshinone IIA increases the bystander effect of herpes simplex virus thymidine kinase/ganciclovir gene therapy via enhanced gap junctional intercellular communicationCloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virusNovel therapeutic approaches for various cancer types using a modified sleeping beauty-based gene delivery systemThe molecular basis of genetic dominanceGold nanoparticles in biology and medicine: recent advances and prospects.Mouse homologues of human hereditary disease.Sugar-based tertiary amino gemini surfactants with a vesicle-to-micelle transition in the endosomal pH range mediate efficient transfection in vitro.Gene therapy for diseases of the nervous system.Gene therapy for cystic fibrosis.Molecular advances in cardiac and cardiovascular disease.Gene therapy and dermatology: more than just skin deep.Development of a self-inactivating lentivirus vector.Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery.Viral vectors in the treatment of Parkinson's disease.Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus.Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model.EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery.Advances in skin gene therapy.Gene therapy for Parkinson's disease: review and update.Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.Tetracycline-regulated cardiac gene expression in vivo.Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells.Gene therapy: here to stay.Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations.Plasmid DNA entry into postmitotic nuclei of primary rat myotubesDelivery of novel macromolecular drugs against HIV-1.Gene therapy with herpes simplex virus vectors: progress and prospects for clinical neuroscience.Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignanciesReversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1Evaluation of beta-globin gene therapy constructs in single copy transgenic mice.Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.Response of donor and recipient cells after transplantation of cells to the ligament and tendon.Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign gene
P2860
Q24645399-B9BBE55B-DD75-439B-B0C3-6008A7C9F3D0Q24682328-2112E030-7C23-4638-B59E-E6789C3626BFQ24803348-3C2946F4-6737-4485-A5E3-E1361F10AB3AQ26741371-4B266064-B054-497F-8A64-0912B68544D2Q26827613-6254EEB7-8755-4EC7-8E4E-710142338922Q28534514-78EE991D-D946-4144-8B61-92651E557EB0Q28576023-D125FF00-AC4B-4D6E-8A23-B0F20FBB78F5Q28660424-2A3947D9-5456-42A6-8F75-8B06D3F6C395Q28972447-3A148228-2096-495A-A58C-91958F7F38D0Q30467305-AEB694D9-7D63-4655-A73E-99086A295F18Q30495383-33219767-87EE-4818-85DA-45F1BEDB46C2Q32081175-08568AFC-0B65-4FD4-8373-527F4DA278D6Q33582065-92CE6BF9-9C77-48AE-9821-9ECD05A1DF4FQ33623207-358E04DB-F7A5-4E17-AE6C-93F5A264B08DQ33641514-F6F6D392-37FB-4DA9-BF4A-45C59D401B3DQ33669657-8963F771-62D8-4380-B3DD-39E32A128163Q33784841-D98B9EA6-3634-4AC0-864C-5A2669A902FCQ33784907-3C9BABA9-F100-45E7-B0B4-4D668313D88BQ33799990-5011B0F6-E545-4E29-9778-CBC776CA5C36Q33816851-19F22ED5-2794-4F4F-8970-F14F1DFD7461Q33822095-CEB4723B-C5AA-4FF4-B1CB-8E188E572874Q33835521-D874EBDD-A3A3-4049-B8CC-1916E7B5EEF4Q33860748-AB789CEF-B644-48C8-82AC-185FB0287000Q34066344-E4A0E19F-55F4-4816-B2D4-F11A3FC0FE0DQ34075060-05B22C60-8CD7-47A1-BC78-59F24EB0A790Q34119491-34543AFE-1AEB-44B0-9945-128968C60A06Q34138051-DFA3E86D-C8CA-44A0-B565-7DEDEC1D719BQ34141635-E78B78E1-BD89-4DAF-A4C2-F641DB4DCADEQ34244510-8CC6C2CD-F65E-4550-8DAC-F764C2D5CE0BQ34279082-DFCFE4FA-827E-4E79-A7DB-6FCCE981DF7FQ34326769-E6F16B04-8369-4637-BFC2-E354BDC47D53Q34345977-1269F418-B371-460F-8CD9-7E1170853D93Q34452681-7591CA92-EEE0-47F7-8CAE-53D685DFD7C3Q34476794-E9EA0733-4F54-4919-A577-7F98C06972A4Q34482357-654DB5CD-0C19-4E3F-8439-A64480BFA4D1Q34604690-A209816D-2643-4C79-8850-0C6EEB10D3DAQ34626844-5D064FDB-0203-4860-B0CA-4C0B67D273C4Q34655806-7A8B9B8E-E931-496C-8C00-B304C04EB273Q34733225-0689DD2E-BB3E-493A-8F0C-EC4C00348270Q35047782-258201A2-70CF-4FD2-A197-7F8BFBDA72A1
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Human gene therapy comes of age.
@ast
Human gene therapy comes of age.
@en
type
label
Human gene therapy comes of age.
@ast
Human gene therapy comes of age.
@en
prefLabel
Human gene therapy comes of age.
@ast
Human gene therapy comes of age.
@en
P356
P1433
P1476
Human gene therapy comes of age
@en
P2093
P2888
P304
P356
10.1038/357455A0
P407
P577
1992-06-01T00:00:00Z
P6179
1044352249